Suvretta Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.2M | Hold |
7,900
| – | – | 0.1% | 66 |
|
|
2025
Q1 | $3.93M | Hold |
7,900
| – | – | 0.15% | 66 |
|
|
2024
Q4 | $4.11M | Buy |
7,900
+640
| +9% | +$333K | 0.14% | 65 |
|
|
2024
Q3 | $4.49M | Hold |
7,260
| – | – | 0.14% | 63 |
|
|
2024
Q2 | $4.01M | Hold |
7,260
| – | – | 0.15% | 57 |
|
|
2024
Q1 | $4.22M | Hold |
7,260
| – | – | 0.16% | 62 |
|
|
2023
Q4 | $3.85M | Hold |
7,260
| – | – | 0.17% | 54 |
|
|
2023
Q3 | $3.67M | Hold |
7,260
| – | – | 0.2% | 56 |
|
|
2023
Q2 | $3.79M | Buy |
7,260
+2,200
| +43% | +$1.15M | 0.2% | 65 |
|
|
2023
Q1 | $2.92M | Buy |
5,060
+1,700
| +51% | +$980K | 0.12% | 59 |
|
|
2022
Q4 | $1.85M | Sell |
3,360
-111,365
| -97% | -$61.3M | 0.08% | 66 |
|
|
2022
Q3 | $58.2M | Sell |
114,725
-6,650
| -5% | -$3.37M | 2.42% | 18 |
|
|
2022
Q2 | $65.9M | Buy |
121,375
+6,306
| +5% | +$3.43M | 2.51% | 14 |
|
|
2022
Q1 | $68M | Sell |
115,069
-155,401
| -57% | -$91.8M | 2.08% | 21 |
|
|
2021
Q4 | $180M | Sell |
270,470
-55,340
| -17% | -$36.9M | 3.49% | 8 |
|
|
2021
Q3 | $186M | Buy |
+325,810
| New | +$186M | 3.14% | 9 |
|
|
2015
Q1 | – | Sell |
-468,500
| Closed | -$58.7M | – | 34 |
|
|
2014
Q4 | $58.7M | Buy |
468,500
+70,800
| +18% | +$8.87M | 4.18% | 11 |
|
|
2014
Q3 | $48.4M | Buy |
397,700
+164,100
| +70% | +$20M | 4.23% | 8 |
|
|
2014
Q2 | $27.6M | Sell |
233,600
-15,900
| -6% | -$1.88M | 2.49% | 22 |
|
|
2014
Q1 | $30M | Sell |
249,500
-72,500
| -23% | -$8.72M | 3.57% | 13 |
|
|
2013
Q4 | $35.9M | Buy |
+322,000
| New | +$35.9M | 4.81% | 3 |
|